• locale

  United States

• market

  PRIVATE

• industry

  Pharmaceuticals

• website

  www.idrx.com/

IDRx is a clinical-stage biopharmaceutical company dedicated to transforming cancer care with intelligently designed precision therapies. The company focuses on developing small molecule tyrosine kinase inhibitors to address limitations in existing precision cancer medicines.